NORGES BANK - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2022$27,777,511
-46.7%
634,045
-19.8%
0.01%
-50.0%
Q3 2022$52,116,025
+67.8%
790,955
+28.6%
0.01%
+75.0%
Q2 2022$31,058,650
-40.6%
614,901
-24.9%
0.01%
-27.3%
Q1 2022$52,283,033
-39.5%
818,457
+1.5%
0.01%
-38.9%
Q4 2021$86,351,000
+13.9%
806,188
+9.4%
0.02%
+5.9%
Q3 2021$75,787,000
+28.0%
737,157
+9.5%
0.02%
+30.8%
Q2 2021$59,195,000
-14.2%
672,973
-5.2%
0.01%
-18.8%
Q1 2021$69,024,000
-21.1%
709,908
-9.0%
0.02%
-20.0%
Q4 2020$87,507,000
-3.6%
780,264
-20.3%
0.02%
-16.7%
Q3 2020$90,782,000
+0.6%
979,314
-15.3%
0.02%
-7.7%
Q2 2020$90,220,000
-1.7%
1,156,671
-26.3%
0.03%
-21.2%
Q1 2020$91,803,000
+14.9%
1,569,812
+57.4%
0.03%
+50.0%
Q4 2019$79,919,000
+48.6%
997,612
+36.2%
0.02%
+37.5%
Q3 2019$53,795,000
-26.5%
732,212
-5.6%
0.02%
-30.4%
Q2 2019$73,157,000
+2.0%
775,544
-13.4%
0.02%0.0%
Q1 2019$71,688,000
+67.9%
895,544
+13.1%
0.02%
+43.8%
Q4 2018$42,705,000
-30.9%
792,1510.0%0.02%
-20.0%
Q3 2018$61,835,000
+5.0%
792,151
-14.6%
0.02%0.0%
Q2 2018$58,867,000
-20.9%
927,333
+14.2%
0.02%
-25.9%
Q1 2018$74,438,000
+27.1%
811,752
+4.5%
0.03%
+28.6%
Q4 2017$58,574,000
+81.3%
776,734
+67.5%
0.02%
+75.0%
Q3 2017$32,305,000
+70.0%
463,695
+23.7%
0.01%
+50.0%
Q2 2017$19,001,000
+2610.6%
375,000
+1400.0%
0.01%
Q4 2016$701,000
+32.3%
25,000
+25.0%
0.00%
Q2 2015$530,00020,0000.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 645,539$69,144,0007.84%
DAFNA Capital Management LLC 206,911$22,162,0005.57%
Eagle Health Investments LP 192,639$20,634,0005.03%
Casdin Capital, LLC 1,550,000$166,021,0004.68%
CADIAN CAPITAL MANAGEMENT, LP 450,657$48,270,0002.65%
Avidity Partners Management LP 995,000$106,574,0002.26%
Integral Health Asset Management, LLC 75,000$8,033,0002.22%
Rock Springs Capital Management LP 859,755$92,088,0002.13%
Boxer Capital, LLC 507,374$54,345,0002.11%
EFG Asset Management (North America) Corp. 112,715$12,082,0001.58%
View complete list of BLUEPRINT MEDICINES CORP shareholders